MDM efferocytosis MDM net efferocytosis was measured at baseline and was found to be lower in the asthma cohort (33.2 (±17.7)%) compared with the healthy controls (45.3 (±15.9)%) although the difference did not reach statistical significance ( p = 0.081) (Fig. 1 ).
← all excerpts
Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.
1
0.0810
0.0810